Most patients rate nausea during peak weeks as the most challenging symptom, but its manageable with medication and resolves by week 12 for the majority
GLP-1s can spur weight loss and health benefits on their own, but the effects are larger and last longer when the drugs are combined with lifestyle changes, a recent review of nearly three dozen studies found
GLP-1-analoger efterliknar effekten av GLP-1, medan tirzepatid (Mounjaro) efterliknar bde GLP-1 och GIP
For instance, Black patients are 19% less likely to be prescribed these drugs than white patients, and Latino patients are 9% less likely to receive prescriptions (Kaplan, 2024)
Standard antacids rarely help
They do not respond to other G protein-coupled receptor (GPCR)-activating hormones, such as GIP (glucose-dependent insulinotropic polypeptide) or glucagon